Company
Novo Nordisk
NYSE:NVO
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
226 stories · page 11 of 12
Novo Nordisk Wegovy surge to continue, says Stifel
Novo Nordisk delivered 30% and 32% growth in sales and operating income respectively in the first half
‘Miracle’ weight-loss drug Wegovy will not be issued through major insurers
Aviva, Axa, and WPA snub the obesity drug
FIVE at FIVE: Pret prices; National Grid plans 12 switch offs; Superdried up; Novo Nordisk’s fat buster; FTSE 100
Here’s Proactive’s round-up of the top financial stories of the day, with helpful links taking you directly to the news
Novo Nordisk weight-loss drug impresses in heart trial
Shares jumped 10% as cardiovascular events were cut by a fifth in Select trial